newsfilter
← Latest News
GlobeNewswire·

Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production

ACTON, Mass., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ:BJDX) ("Bluejay" or the "Company") announced that it has completed commercial-scale production of both polyclonal and monoclonal